Home - Products - Others - Other Targets - (D-Pro4,D-Trp7·9·10)-Substance P (4-11)

(D-Pro4,D-Trp7·9·10)-Substance P (4-11)

CAS No. 86917-57-9

(D-Pro4,D-Trp7·9·10)-Substance P (4-11)( ——— )

Catalog No. M40452 CAS No. 86917-57-9

[D-Pro4,D-Trp7,9,10] Substance P (4-11) is a potent tachykinin antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    (D-Pro4,D-Trp7·9·10)-Substance P (4-11)
  • Note
    Research use only, not for human use.
  • Brief Description
    [D-Pro4,D-Trp7,9,10] Substance P (4-11) is a potent tachykinin antagonist.
  • Description
    [D-Pro4,D-Trp7,9,10] Substance P (4-11) is a potent tachykinin antagonist.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    86917-57-9
  • Formula Weight
    1207.43
  • Molecular Formula
    C62H74N14O10S
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Bailey SJ, et al. Effect of the tachykinin antagonist, D-Pro4, D-Trp7,9,10 substance P-(4-11), on tachykinin- and histamine-induced inositol phosphate generation in intestinal smooth muscle. Naunyn Schmiedebergs Arch Pharmacol. 1987 Mar;335(3):296-300. ?
molnova catalog
related products
  • 3-Phenylbutyric acid

    3-Phenylbutyric acid isolates Rhodococcus rhodochrous PB1 from compost soil and is metabolized by initial oxidation of the benzene ring and by initial oxidation of the side chain.

  • Geniposide

    Geniposide is an iridoid glycoside with a variety of biological activities including neuroprotective,anti-diabetic,antiproliferative,and antioxidative activity.

  • Methyl retinoate

    Methyl retinoate (Retinoic acid, methyl ester) induces aseptic inflammation at the site of administration in in vivo experiments, which causes an increase in the number of leukocytes in the blood and a decrease in the levels of red blood cells and Hb.Methyl retinoate promotes spontaneous leukemia.Methyl retinoate can be Used in the treatment of gastric hypertrophy and ulcers due to vitamin A deficiency.